The multi-epitope peptide vaccine HisDTC was previously designed, as detailed in [23 (link)]. The peptides were synthesized by GenScript Biotech (Leiden, The Netherlands) with purity ≥ 95% and stored at −20 °C until encapsulation.
TLRL-2 (Pam3CSK4) and TLRL-3 (Poly(I:C) HMW (VacciGrade™, InvivoGen, Toulouse, France) were used as adjuvants when needed.
Free full text: Click here